Clinical Locations
Huntsman Cancer Institute - Cancer Research North
Board Certification
|
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Hematology)
American Board of Internal Medicine (Sub: Medical Oncology)
|
Patient Rating
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Dr Shah seems to be a very caring Doctor, and a great listener. I felt very comfortable with him and my husband thinks we have a good Doctor taking care of me.
Outstanding at listening, not only to me but his entire team. Eveyone had a voice. It was very nice and reassuring.
Very knowledgeable, conversant in terms I could understand, openly shared research information with me. Included home Physician in matters. Also included wife in all options.
We are truly fortunate to have Dr. Shah in our community. Will forever be grateful for his care, knowledge, competency and commitment to a cure and care. THank you!
Very caring and professional
Dr. Shah has always been very knowledgeable, very professional and very much concerned for his patients. I'm fortunate to have had Dr. Shah as my oncologist for nearly five years now.
Dr. Shah continues to be EXCELLENT in his attention and care. He is very knowledgeable and follows my situation very attentively, I am in the care of a caring and loving physician, and I feel it with every visit...
Havent seen Dr Shah for a few months
I felt he was very concerned with my condition, answered all my questions, explained everything that I was going to be going through. Very helpful
Caring, professional, unde
I was impressed by the time and care I received.
My doctor was awesome
It shows when people like working at any place, and I've noticed that doctors, nurses and staff in general like working at Huntsman. Always a high degree of professionalism, from the doctors to the cafeteria staff. Dr Shah is always very kind and feels like he knows what he's doing. Highly skilled doctor. All his PAs are always very kind and thoughtful. Always a good experience.
Dr Shah is a wonderful caring doctor!
He was so kind. He answered all of our questions in a way that we understood.
Sr. Shah listens to my concerns and gives me answers in a way that I can understand. He also explains the good and bad things about my health in a way that I can understand. He is very caring and understanding.
My cancer diagnosis has been terrifying. There is so much new information and so many decisions to be made. I am scared, but I am absolutely confident in one thing: Huntsman is the best place for me to be and Dr. Shah will work in my best interest. For this I am extremely grateful.
Dr. Shah is a wonderful person. And highly qualified.
Like all Dr.s he is very busy.
I found Dr Shah to be very caring, understanding and professional. Dr Shah listened to me and put me at ease.
Dr Shah is great.
His a real good doctor.
very human and caring professional
He was fine.
Was very efficient and appropriate. The only questions he did not answer were the ones I forgot to ask
Outstanding Oncologist!
Dr. Shah was warm and personable. He is knowledgeable and made me feel confident in his assessment and recommendations.
Dr. Shah took the time to listen to my symptoms, discuss treatment options and valued my feedback. He addressed all my concerns and gave me a predictable future
She was wonderful!!
Excellent. Highly recommend him. [TRANSLATED]
I really like how Dr Shah listens and addresses your needs.
Excellent, supportive, thorough care. I am in remission. All he said was spot on, I am so appreciative and grateful
It has been a great experience to work with Dr. Shah. His interaction with me was very pleasant and helpful.
I am please beyond any and all expectations with all the treatments I have received at Huntsman since my condition was diagnosed
Clear straightforward communication style. Willing to share uncertainties about future treatment plans
Dr. Shah was great. He discussed my past medical history and followed up on the next steps.
He explained information well, never seemed rush, very thorough, hes caring and brings comfort to the patient and their family. Very positive throughout the entire course of treatment, which brings hope and comfort.
Dr. Shah is very knowledgeable and explained my treatment plan very well.
The N/P wes very thorough in explaining my diagnosis, and ensuring discussion, she was great
After Dr. Martha Glen's retirement, I was concerned about her replacement. Dr. Shah was exceptionally through and helpful. No one can replace Dr. Glen's "bedside" manner, but Dr. Shah was a pleasant surprise.
The ratings in this section would have all been very good if I had taken it upon myself to ask more questions
Very satisfied so far
I did not see Dr. Shah. In past meetings, he was very good and helpful in every way.
Very impressed with his knowledge and experience
Good at explaining my results
Dr. Shah took me seriously and gave me the time and attention I needed. I felt like I was getting the best advice possible.
The whole experience was very good
Dr Shah is a great doctor and provides excellent patient care.
Dr Harsh Shah is Great - he listens and we discuss things each time we meet.
He listens and helps me understand my disease.
Dr Shah is thoroughly familiar with the process and subject matter. Explained everything in great detail, listened with utmost care, taking copious notes. My wife and I feel we are in the most capable hands.
I am so very pleased to have Dr. Shah as my oncologist. I just had my first meeting with Dr. Shah where he discussed the type of cancer I have, and while the diagnosis is not something anyone would want to hear, I immediately felt very comfortable with him and very confident in his abilities. His recommended course of action is the best I could hope for under the circumstances. It is a reasonable approach and I am so fortunate to be under his care.
I am kept informed of my health
Dr. Shah has been amazing. He is very good at listening and explaining. You can tell he is really giving his all to help his patients!
The first time I met Dr. Shah I immediately knew I was in good hands and I had complete confidence in his abilities to provide me with the most effective treatment plan.
Dr Shah was knowledgable and curtious. His care was very good and he explained my illness in a way I could understand.
Very good doctor, caring, intelligent and works well with me !
Dr Shah is helpful with me and managing my cancer needs. If there is something that I don't understand he takes the time to explain further so I am aware of what is going on.
Dr. Shah is fantastic.
excellent and caring. Makes everything very clear and understandable.
Smart, precessional, answers questions. Remembers things about us. He's great!¿
Explained pros and cons of doing a biopsy of two apparent enlarged lymph nodes.
Dr. Shah is the best. The staff he has assembled are also great.
The physician was very helpful and took the time to first explain and then offer information and answered all my questions. He helped my to be able to ask questions.
Both Dr. Patel and Dr. Shah are very articulate and very good at explaining the disease and the procedures involved.
he is a warm and caring dr.
extremely attentive, shares information, values patient feedback. I trust him completely
Love and respect for Dr. Shah. He cares so much about patients needs.
Very knowledgeable and professional.
Very good trusting doctor. Good bedside manner. Understanding.
Dr. Shah is a very caring physician with a very good bedside manner.
Very understanding person, Dr. Easy to talk to and he takes time to listen and explain what is going on.
Good
Dr. Shah has settled in and was awesome during my recent appointment. I was spoiled by Dr. Glen and was expecting a smoother transition.
Dr. Shah is great. His care and concern are exemplary.
We really like Dr Shah. Thanks!
I am fortunate to be in the care of Dr Shah.
very knowledgeable, I feel comfortable with what he suggests for me and my care. Explains things thoroughly.
Dr. Shah is a warm caring person. Highly professional and able to explain to the patient the details of treatment in words that a lay person can understand.
not only is he an knowledgeable, medical practitioner, but he's kind, personable and assures me that he's interested in my well-being
Dr, Shah has been very good in all aspects of the care he has provided during my cancer battle for more than two years.
He's terrific! Very thorough and compassionate.
Jessica Coon is amazing, always.Great to meet Dr. Shah. very impressive.
I was giving bad news on blood test results will no directional guidance where to go next.
Both Dr. Shah and the PA were very responsive to my questions and concerns. I left feeling very good about the plans we made moving forward.
Dr Shah is a very caring concerned doctor
Since August, 2020, when I was diagnosed with Non Gastric MALT Lymphoma, Dr. Shah has provided excellent advice, care and concern in treating the cancer.
Dr. Shah was personable, attentive, and knowledgable. I felt understood and comfortable trusting him with my care.
I appreciate Dr. Shah's knowledge and experience working with my disease and the many complications that I have that make me a very complex case.
Dr. Shah is amazing. I have trusted him with my life, and would again!
Dr. Shah is terrific
So far I have been pleased with all aspects of my treatment
Trust him with my life! Great bedside manner!
An empathetic and wonderful human being
Doctor shah was amazing and treated me so good and helped me get better.
Thank you Dr Shah for everything you do! Your kindness, honesty, communication, and compassion are very appreciated! We are very thankful to have you as our motherÕs provider. We will always remember the time you have taken, even while you were on vacation, to reach out and care for my mom. Thank you so very much!
Awesome Doctors. Love my Doctors here and study coordinator. Everyone is excellent at their job
good
Dr. Harsh R Shah diagnosed my Extranodal MZL with pleural effusions in [DATE REMOVED] and provided treatment to put the cancer in remssion in [DATE REMOVED]. Dr. Shah is an outstanding doctor whose knowledge and patient care are the very best.
Very caring understanding and explain everything in details very well
I thank Dr Shah for treating me with respect and assuring me of the future.
He answered all of our questions, and didn't rush us. We told him of our we questions about the drug we were taking and the costs and he had his pharmacist meet with us to help with getting the drug affordable.
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Associate Professor (Clinical) |
|---|---|
| Academic Divisions |
Hematology & Hematologic Malignancies
|
| Board Certification |
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Hematology)
American Board of Internal Medicine (Sub: Medical Oncology)
|
Education history
| Undergraduate | Biomedical Engineering - University of Michigan | B.S.E. |
|---|---|---|
| Graduate Training | Biomedical Engineering - University of Michigan | M.S.E. |
| Professional Medical | Osteopathic Medicine - Kirksville College of Osteopathic Medicine - AT Still University of Health Sciences | D.O. |
| Residency | Internal Medicine - Indiana University School of Medicine | Resident |
| Fellowship | Hematology-Oncology - Karmanos Cancer Institute - Wayne State University | Fellow |
Selected Publications
Journal Article
- Orellana-Noia VM, Reed D, McCook AA, Sen JM, Barlow CM, Malecek MK, Watkins MP, Kahl BS, Spinner MA, Advani R, Voorhees TJ, Snow A, Grover NS, Ayers AA, Romancik J, Liu Y, Huntington SF, Chavez JC, Saeed H, Lazaryan A, Raghunathan V, Spurgeon SE, Ollila TA, Del Prete C, Olszewski A, Ayers EC, Landsburg DJ, Echalier B, Lee J, Kamdar M, Caimi PF, Fu T, Liu J, David KA, Alharthy H, Law JY, Karmali R, Shah HR, Stephens DM, Major A, Rojek AE, Smith SM, Yellala A, Kallam A, Nakhoda S, Khan N, Sohail MA, Hill BT, Barrett-Campbell O, Lansigan F, Switchenko JM, Cohen JB, Portell C (2021). Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions. Blood, 139, 413-423.
- Shah HR, Stephens D (2021). Is there a role for anti-CD20 antibodies in CLL?. Hematology. American Society of Hematology. Education Program, 2021(1), 68-75.
- Shah H, Vaishampayan (2018). Therapy of Advanced Prostate Cancer: Targeting the Androgen Receptor Axis in Earlier Lines of Treatment. Targeted oncology, 13(6), 679-689.
- Shah H, Bradford C, Sayar (2015). Acute Promyelocytic Leukemia Presenting with Severe Marrow Fibrosis. Case reports in hematology, 2015, 826894.
- Shah H, Jang H, Singh P, Kosti J, Kin A, Alavi A, Ratanatharathorn V, Ayash L, Uberti J, Ramchandren R, Kim S, Deol (2022). Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents. Leukemia & lymphoma, 63(4), 813-820.
- Shah H, Stephens D, Seymour J, Maddocks (2021). Incorporating Novel Targeted and Immunotherapeutic Agents in Treatment of B-Cell Lymphomas. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 41, 1-18.
- Shah H, Kim S, Singh P, Alavi A, Ratanatharathorn V, Ayash L, Uberti J, Deol (2020). Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts. American journal of hematology, 95(2), 198-204.
- Vaishampayan U, Shah H, Asad MF, Shi D, Dickow B, Suisham S, Domina J, Cher ML, Samantray J, Aoun H (2020). Adrenal Metastases as Sanctuary Sites in Advanced Renal Cancer. Journal of kidney cancer and VHL, 7(4), 1-7.
- Stephens DM, Huang Y, Ruppert AS, Walker JS, Canfield D, Cempre CB, Fu Q, Baker S, Hu B, Shah H, Vadeboncoeur R, Rogers KA, Bhat S, Jaglowski SM, Lockman H, Lapalombella R, Byrd JC, Woyach J (2022). Selinexor combined with ibrutinib demonstrates tolerability and safety in advanced B-cell malignancies: A phase I study. Clinical cancer research, 28(15), 3242-3247.
- Shah H, Jang H, Kim S, Halwani A (2022). A comprehensive SEER registry analysis of elderly patients with classical Hodgkin lymphoma based on treatment era and race. British journal of haematology, 200(5), 579-586.
- Rock CB, Chipman JJ, Parsons MW, Weil CR, Hutten RJ, Tao R, Tward JD, Shah HR, Hu B, Stephens DM, Gaffney D (2022). Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy. Advances in radiation oncology, 7(6), 101035.
- Desai SH, Spinner MA, David K, Bachanova V, Goyal G, Kahl B, Dorritie K, Azzi J, Kenkre VP, Arai S, Chang C, Fusco B, Sumransub N, Hatic H, Saba R, Ibrahim U, Harris EI, Shah H, Murphy J, Ansell S, Jagadish D, Orellana-Noia V, Diefenbach C, Iyenger S, Rappazzo KC, Mishra R, Choi Y, Nowakowski GS, Advani RH, Micallef I (2023). Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma. American journal of hematology,
- Fenlon JB, Hutten RJ, Johnson SB, Hu B, Shah H, Stephens DM, Maity A, Gaffney DK, Tao (2022). Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era. Leukemia & lymphoma, 64(2), 1-8.
- Chavez JC, Foss FM, William BM, Brammer JE, Smith SM, Prica A, Zain JM, Tuscano JM, Shah H, Mehta-Shah N, Ramakrishnan Geethakumari PR, Wang BX, Zantinge S, Wang L, Zhang L, Boutrin A, Zhao W, Cheng L, Standifer N, Hewitt L, Enowtambong E, Shao W, Sharma S, Carlesso G, Moscow JA, Siu L (2023). Targeting the Inducible T-cell Costimulator (ICOS) in patients with Relapsed/Refractory T-Follicular Helper Phenotype Peripheral T-Cell and Angioimmunoblastic T-Cell Lymphoma. Clinical cancer research,
- Parsons MW, Rock C, Chipman JJ, Shah HR, Hu B, Stephens DM, Tao R, Tward JD, Gaffney D (2023). Secondary malignancies in non-Hodgkin lymphoma survivors: 40¿years of follow-up assessed by treatment modality. Cancer medicine, 12(3), 2624-2636.
- Wagner CB, Boucher K, Nedved A, Micallef IN, Desai S, Hatic H, Goyal G, Zacholski E, Fegley A, Sigmund AM, Bond DA, Samuels C, Kamdar MK, Ba Aqeel S, Torka P, MacDougall K, Borogovac A, Rajeeve S, Sundaram S, Fedak K, Modi D, Travers E, Ayyappan S, Chilakamarri N, Brem EA, Ermann DA, Fitzgerald LA, Hu B, Stephens DM, Shah (2023). Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of realworld outcomes. Haematologica, 108(11), 3025-3032.
- Goyal G, Lau KW, Wang X, Davidoff AJ, Huntington SF, Jamy O, Calip G, Shah H, Stephens DM, Miksad R, Parikh RB, Takvorian S, Neparidze N, Seymour E (2023). The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021. JAMA network open, 6(6), e2316642.
- Ermann DA, Vardell VA, Shah H, Fitzgerald L, Tao R, Gaffney DK, Stephens DM, Hu (2024). Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy. Clinical lymphoma, myeloma & leukemia, 24(2), 94-104.e6.
- Desai SH, Spinner MA, Evens AM, Sykorova A, Bachanova V, Goyal G, Kahl B, Dorritie K, Azzi J, Kenkre VP, Chang C, Michalka J, Ansell SM, Fusco B, Sumransub N, Hatic H, Saba R, Ibrahim U, Harris EI, Shah H, Wagner-Johnston N, Arai S, Nowakowski GS, Mocikova H, Jagadeesh D, Blum KA, Diefenbach C, Iyengar S, Rappazzo KC, Baidoun F, Choi Y, Prochazka V, Advani RH, Micallef (2023). Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era. Blood advances, 7(23), 7295-7303.
- Soumerai JD, Barrientos JC, Ahn IE, Coombs CC, Gladstone DE, Hoffmann MS, Kittai AS, Jacobs RW, Lipsky A, Patel K, Rhodes JM, Skarbnik AP, Thompson MC, Ermann DA, Reville PK, Shah HR, Brown JR, Stephens D (2024). Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL. Blood advances,
- Baron K, Anto E, Esther J, Vardell VA, Pappas L, Bock A, Ermann DA, Fitzgerald LA, Hu B, Shah H (2025). Comparison of Real-World Outcomes in Patients With Follicular Lymphoma Treated With BR Versus RCHOP-Like Regimens. Clinical lymphoma, myeloma & leukemia,
- Desai SH, Moskowitz AJ, Merryman RW, Shah HR, Pederson LD, Geyer S, Ganesan N, Chang T, Othman T, Falade AS, Shah GL, Durani U, Sumransub N, Ng LS, Baron K, Ong SY, Yoon K, Ansell SM, Armand P, Iyengar S, Micallef IN, Stuver RN, Herrera AF, Mei M (2025). PD-1-based combinations before autologous transplant are associated with improved outcomes in classical Hodgkin lymphoma. Blood,
- Advani RH, Kelsey CR, Armand P, Bello CM, Benitez CM, Bond D, Chen W, Cherian S, Czader M, Dabaja B, Daly ME, Frosch Z, Gordon LI, Hansen N, Herrera AF, Hochberg EP, Hoppe RT, Isufi I, Johnston PB, Kelly K, Kenkre VP, Kline J, Lynch RC, McConathy J, Morgan D, Niu A, Paul S, Rabinovitch R, Salavati A, Sano D, Shah H, Spinner M, Svoboda J, Winter JN, Yahalom J, Yang JC, Montgomery S, Stehman (2026). Hodgkin Lymphoma, Version 1.2026, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network, 24(2), 41-60.
- Ermann D, Vardell V, Zacholski E, Fegley A, Modi D, Fedak K, Sundaram S, Rajeeve S, Goyal G, Hatic H, Torka P, Ba Aqeel S, Borogovac A, MacDougall K, Kothari S, Kress A, Travers E, Chilakamarri N, Brem E, Ayyappan S, Sigmund A, Bond D, Fitzgerald L, Wagner C, Hu B, Stephens DM, Shah (2026). Comparison of Outcomes With Novel Versus Traditional Chemotherapy Regimens for Relapsed and Refractory Classical Hodgkin Lymphoma. Clinical lymphoma, myeloma & leukemia,
Review
- Salem AE, Shah HR, Covington MF, Koppula BR, Fine GC, Wiggins RH, Hoffman JM, Morton K (2022). PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies. Cancers, 14(23),
Case Report
- Shah H, McPherson K, Mansour A, Ramirez-Santrich C, Nassiri M, Shahda (2016). Neuroendocrine Differentiation of a Primary BRAF Mutant Colon Cancer in a Patient With a History of Hairy Cell Leukemia. Clinical colorectal cancer, 15(4), e235-e239.
Letter
- Shah H, Kim S, Klimecki S, Charlson K, Uberti J, Schiffer CA, Fiala MA, Seymour (2022). Racial disparities in time to hematopoietic cell transplant among patients with hematologic malignancies at a large urban academic center. Bone marrow transplantation, 57, 1213-1215.
- Vardell VA, Ermann DA, Fitzgerald LA, Shah HR, Hu B, Stephens D (2023). Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia. American journal of hematology, 98(7), E172-E174.
- Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV, David KA, Torka P, Hashmi H, Hess B, Barta SK, Romancik JT, Cohen JB, Annunzio K, Kittai AS, Reneau J, Zurko J, Nizamuddin IA, Winter JN, Gordon LI, Ma S, Patel R, Nastoupil L, Ahmed S, Karmali (2023). Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. Journal of hematology & oncology, 16(1), 111.
- Vardell VA, Ermann DA, Fitzgerald L, Shah H, Hu B, Stephens D (2024). T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments. American journal of hematology, 99(3), 494-496.